LBO — ASPIRUS STEVENS POINT HOSPITAL
IRR: 18.6% | MOIC: 2.35x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.6%
IRR
2.35x
MOIC
$166.0M
Entry EV
$270.2M
Exit EV
$85.4M
Equity Invested
Sources & Uses
S&UTotal · $166.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $64.5M | 38.8% | |
| Sub Debt | $16.1M | 9.7% | |
| Equity | $85.4M | 51.5% | |
| Enterprise Value | $161.1M | 97.1% | |
| Transaction Fees | $4.8M | 2.9% | |
| Total Uses | $166.0M | 100.0% |
Interpretation
INTAt 2.35x MOIC and 18.6% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $25.7M |
| Exit Ev | $270.2M |
| Net Debt At Exit | $69.8M |
| Equity At Exit | $200.4M |
| Equity Invested | $85.4M |
| Total Value Created | $115.0M |
| Value From Growth | $101.0M |
| Value From Multiple | $8.1M |
| Value From Deleveraging | $10.8M |